Predictive role of imaging in sentinel lymph node dissection for melanoma

Area of Science:

• Oncology
• Nuclear Medicine
• Surgical Pathology

Background:

• Metastatic melanoma requires accurate staging, often involving sentinel lymph node biopsy (SLNB).
• Identifying the most radioactive lymph node is crucial in SLNB, but its accuracy in predicting metastasis is under investigation.

Purpose of the Study:

• To evaluate if lymphoscintigraphy imaging can predict a higher miss rate in metastatic melanoma patients when only the most radioactive lymph node is removed.
• To assess the correlation between lymph node radioactivity and metastatic presence.

Main Methods:

• Retrospective analysis of 67 metastatic melanoma patients undergoing SLNB.
• Correlation of lymph node radioactive counts and pathology results.
• Image interpretation by nuclear medicine physicians to assess changes in lymph node intensity over time.

Main Results:

• In 19% of cases, the most radioactive node was negative for metastasis, while a less radioactive node was positive.
• Lymphoscintigraphy imaging showed a sensitivity of 31%, specificity of 91%, PPV of 44%, and NPV of 85% for predicting negative metastasis in the most radioactive node.
• Nuclear medicine physicians identified dynamic imaging as having a role in surgical planning.

Conclusions:

• Lymphoscintigraphy demonstrates high specificity and NPV but modest sensitivity and PPV for identifying the most radioactive lymph node in melanoma SLNB.
• Dynamic imaging via lymphoscintigraphy aids surgical planning, but protocol optimization is needed to improve accuracy.
• Current imaging protocols may benefit from refinement to reduce the risk of missing metastatic disease in non-most radioactive lymph nodes.